UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Yelp
YELP
|
$189M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$180M |
| 3 |
General Motors
GM
|
$152M |
| 4 |
American Express
AXP
|
$152M |
| 5 |
Comcast
CMCSA
|
$126M |
Top Sells
| 1 |
eBay
EBAY
|
$346M |
| 2 |
Crown Castle
CCI
|
$300M |
| 3 |
Cardinal Health
CAH
|
$223M |
| 4 |
Gilead Sciences
GILD
|
$170M |
| 5 |
Apple
AAPL
|
$159M |
Sector Composition
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.46% |
| 4 | Industrials | 10.12% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Home Depot
HD
$406B
| $375M | 0.43% |
4,554,206
+115,087
| +3% | +$9.48M |
|
|
CELG
52
DELISTED
Celgene Corp
CELG
| $367M | 0.42% |
4,342,318
-179,968
| -4% | -$15.2M |
|
53
McDonald's
MCD
$226B
| $350M | 0.4% |
3,611,756
+183,917
| +5% | +$17.8M |
|
|
AGN
54
DELISTED
ALLERGAN INC
AGN
| $350M | 0.4% |
3,149,940
-400,734
| -11% | -$44.5M |
|
55
Occidental Petroleum
OXY
$45.6B
| $338M | 0.39% |
3,706,559
+87,435
| +2% | +$7.97M |
|
56
Eli Lilly
LLY
$661B
| $333M | 0.38% |
6,525,574
+471,129
| +8% | +$24M |
|
57
3M
MMM
$81B
| $316M | 0.36% |
2,692,749
+85,586
| +3% | +$10M |
|
58
ConocoPhillips
COP
$118B
| $305M | 0.35% |
4,313,625
+129,168
| +3% | +$9.13M |
|
|
VIAB
59
DELISTED
Viacom Inc. Class B
VIAB
| $301M | 0.34% |
3,451,306
+814,392
| +31% | +$71.1M |
|
60
EOG Resources
EOG
$65.8B
| $292M | 0.33% |
3,474,630
-865,212
| -20% | -$72.6M |
|
61
MetLife
MET
$53.6B
| $289M | 0.33% |
6,022,917
+78,369
| +1% | +$3.77M |
|
62
Bristol-Myers Squibb
BMY
$96.7B
| $287M | 0.33% |
5,393,991
-172,204
| -3% | -$9.15M |
|
63
Thermo Fisher Scientific
TMO
$183B
| $287M | 0.33% |
2,573,910
-81,820
| -3% | -$9.11M |
|
|
DFS
64
DELISTED
Discover Financial Services
DFS
| $286M | 0.33% |
5,110,769
-743,162
| -13% | -$41.6M |
|
65
Simon Property Group
SPG
$58.7B
| $282M | 0.32% |
1,968,627
+433,158
| +28% | +$62M |
|
66
Goldman Sachs
GS
$221B
| $282M | 0.32% |
1,589,567
-10,231
| -0.6% | -$1.81M |
|
67
Liberty Global Class A
LBTYA
$4.03B
| $281M | 0.32% |
7,668,421
+2,559,071
| +50% | +$93.9M |
|
68
CVS Health
CVS
$93B
| $281M | 0.32% |
3,927,344
+22,466
| +0.6% | +$1.61M |
|
69
Colgate-Palmolive
CL
$67.7B
| $279M | 0.32% |
4,285,011
+66,397
| +2% | +$4.33M |
|
|
70
Regeneron Pharmaceuticals
REGN
$59.8B
| $279M | 0.32% |
1,015,189
+652,839
| +180% | +$180M |
|
71
Estee Lauder
EL
$33.1B
| $278M | 0.32% |
3,691,237
-614,750
| -14% | -$46.3M |
|
72
Kellanova
K
$27.5B
| $274M | 0.31% |
4,784,105
-819,828
| -15% | -$47M |
|
73
LyondellBasell Industries
LYB
$17.4B
| $263M | 0.3% |
3,273,870
+76,340
| +2% | +$6.13M |
|
74
Abbott
ABT
$230B
| $262M | 0.3% |
6,846,696
-13,970
| -0.2% | -$535K |
|
75
Infosys
INFY
$69B
| $261M | 0.3% |
36,821,472
+16,256,800
| +79% | +$115M |
|